Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400)

Clinical Trials

Institution: The study is being conducted at hundreds of sites in the United States. A full list of sites at which Lung-MAP is currently being conducted is available on the website

Type: Multi-Center Trial


Squamous cell lung cancer. Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.

Dates: June 16, 2014 - January 1, 2022

Disease: Lung Cancer


Watch the video to learn more about the Lung-MAP trial.

Page last updated: February 23, 2021

Join Laura Dern's Team!
Join Laura Dern's Team, | Jun 20, 2021
, | Jun 24, 2021